杨红枚,华中科技大学同济医学院基础医学院人才引进特聘教授、博士生导师。毕业于武汉大学病毒学专业;留学美国十年,先后在哈佛医学院和美国生物医药公司从事病毒免疫、蛋白质代谢和肿瘤生物学的研究及肿瘤治疗药物的研发。现任湖北省微生物学学会常务理事,微生物及免疫学会理事,国家自然科学基金委和教育部通讯评审专家等社会职务。共计发表科研论文30余篇,其中已被SCI收录近二十篇。主要论文: 1. Chen X, Han W, Ruan A, Zhao Y, Xu Z, Lu X, Yang H*, Zhang X*. miR-141 is A Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression. Clinical Cancer Research. 2014 ( IF:7.8,共同通讯作者)2. Yang H, Chen X, Wang X, Li Y, Chen S, Qian X, Wang R, Chen L, Han W, Ruan A, Du Q, Olumi AF, Zhang X*. Inhibition of PP2A Activity Confers a TRAIL-sensitive Phenotype During Malignant Transformation. Mol Cancer Res, Feb;12(2):217-27, 2014 ( IF:4.6,第一作者)3. Wang X. Chen X, Wang R, Xiao P, Xu Z, Chen L, Han W, Ruan A, Yang H*, Zhang X*. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Oncol Rep,30(2): p. 643-50. 2013 ( IF:2.2,共同通讯作者)4. Hongmei Yang, Charles H. Lin, Gang Ma, Michael Baffi and Marc G. Wathelet Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. FEBS J. (Eur. J. Biochem.); 269(24): 6142-51, 2002 Dec. 5. Hongmei Yang, Charles H. Lin, Gang Ma, Michael Baffi and Marc G. Wathelet Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators. J Biol Chem.; 278(18): 15495-504, 2003 May 2.6. Hongmei Yang, Gang Ma, Michael Baffi and Marc G. Wathelet. Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-beta gene promoter. FEBS J. (Eur. J. Biochem.); 271(18): 3693-703, 2004 Sep.7. Hongmei Yang, Wei Wei , Michael Menconi, and Per-Olof Hasselgren. Dexamethasone-induced Protein Degradation in Cultured Myotubes is p300/HAT-dependent. Am I Physiol Regul Integr Comp Physiol.; 292(1):R337-4, 2007 Jan.8. Hongmei Yang, Joshua Mammen, Micahel Menconi, Per-Olof Hasselgren. Expression and Activity of C/EBPbeta and delta are Upregulated by Dexamethasone in Skeletal Muscle. J Cell Physiol.; 204(1): 219-26, 2005 July.9. Hongmei Yang, Mike Menconin, Per-Olof Hasselgren. Dexamethasone Upregulates the Expression of the Nuclear Cofactor p300 and its Interaction with C/EBP BETA in Cultured Myotubes. J Cell Biochem.; 94(5): 1058-67, 2005 Apr 1.10. Xiaoping Zhang, Liang Zhang, Hongmei Yang, Xu Huang, Hasan Otu, Towia A. Libermann,, William C. DeWolf, Roya Khosravi-Far, Aria F. Olumi. c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer Cells. Cancer Res; 67(19): 9425-34,2007 Oct 1. 11. Wei Wei , Hongmei Yang , Peirang Cao , Michael Menconi, and Per-Olof Hasselgren. Treatment of Cultured Myotubes with the Proteasome Inhibitor β-lactone Increase the expression of the Transcription Factor C/EBP β. Am J Physiol Cell Physiol.; 292(1):C216-26, 2007 Jan.12. Wei Wei , Hongmei Yang, Peirang Cao , Michael Menconi, Petkova V, Hasselgren PO. Degradation of C/EBP β in cultured Myotubes is Calpain-dependent. J Cell Physiol.; 208(2): 386-98,2006 Aug.13. Hasselgren PO, Menconi MJ, Fareed MU, Yang H, Wei W, Evenson A. Novel aspects on the regulation of muscle wasting in sepsis. Int J Biochem Cell Biol. 2005 Oct;37(10):2156-68. Epub 2005 Mar 1314. Wei Wei, Fareed MU, Evenson A, Menconi MJ, Hongmei Yang , Petkova V, Hasselgren PO. Sepsis Stimulates Calpain Activity in Skeletal Muscle by Decreasing Calpastatin Activity but Does not Activate Caspase-3. Am J Physiol Regul Integr Comp Physiol. 2005 Mar; 288(3):R580-90.15. Xiaoping Zhang, Tai-Guang Jin, Hongmei Yang, William C. DeWolf, Roya Khosravi-Far and Aria F. Olumi. Persistent c-FLIP(L) Expression is Necessary and Sufficient to Maintain Resistance to Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Prostate Cancer. Cancer Res. 2004 Oct 1; 64(19): 7086-91. 16. Menconi MJ, Wei W, Hongmei Yang, Wray CJ, Hasselgren PO. Treatment of Cultured Myotubes with the Calcium Ionophore A23187 Increases Proteasome Activity via a CaMK II-caspase-calpain-dependent Mechanism. Surgery. 136(2): 135-42, 2004 Aug. 主要著作:杨红枚参编,《病毒转基因技术原理》。科学出版社,2014年。科研项目:1. MicroRNA-141调控HCV复制的机制研究,病毒学国家重点实验室开放课题,2014-2016年;2. 恶病质肌肉萎缩中Myostatin表达调控的机制研究,国家自然科学基金面上项目,2012-2015年;3. 病毒激活因子(VAF)调控丙型肝炎病毒诱导的干扰素表达机制的研究,国家自然科学基金面上项目,2011-2013年。4. 恶病质肌肉萎缩中Myostatin表达调控的机制研究,湖北省科技厅面上项目,2011-2012年;5. 丙型肝炎病毒感染的肝细胞对TRAIL敏感的机制研究,湖北省卫生厅科研一般项目,2011-2012年。6. HCV感染的肝细胞对TRAIL敏感的机制研究,华中科技大学自主创新研究基金资助项目,2010-2012年。
序号 名称
您需要订阅学者后可以查看合作学者!
序号 名称   论文数量
1医学------------论文:28篇
2临床医学------------论文:26篇
3理学------------论文:13篇
4生物学------------论文:12篇
5基础医学------------论文:2篇
序号 名称   论文数量
1CELL DEATH DIS------------论文:6篇
2EXP CELL RES------------论文:4篇
3FRONT GENET------------论文:4篇
4AGING-US------------论文:4篇
5ONCOL REP------------论文:4篇
6ONCOTARGET------------论文:3篇
7INT J ONCOL------------论文:3篇
8FRONT ONCOL------------论文:3篇
9CLIN TRANSL MED------------论文:3篇
10J CANCER------------论文:3篇
11J EXP CLIN CANC RES------------论文:2篇
12ONCOL LETT------------论文:2篇
13CANCER CELL INT------------论文:2篇
14BMC CANCER------------论文:2篇
15UROL ONCOL-SEMIN ORI------------论文:2篇
16CELL PHYSIOL BIOCHEM------------论文:2篇
17ADV SCI------------论文:2篇
18CLIN CANCER RES------------论文:2篇
19INT J BIOL SCI------------论文:2篇
20MOL CANCER RES------------论文:2篇
21J CANCER RES CLIN------------论文:1篇
22J TRANSL MED------------论文:1篇
23THERANOSTICS------------论文:1篇
24CELL DEATH DISCOV------------论文:1篇
25BIOACT MATER------------论文:1篇
26GENOMICS------------论文:1篇
27LIPIDS HEALTH DIS------------论文:1篇
28FRONT BIOSCI-LANDMRK------------论文:1篇
29BBA-MOL CELL BIOL L------------论文:1篇
30BIOCHEM BIOPH RES CO------------论文:1篇
31ONCOTARGETS THER------------论文:1篇
32BIOMED PHARMACOTHER------------论文:1篇
33QUAL LIFE RES------------论文:1篇
34MOL THER------------论文:1篇
35BIOMARKERS------------论文:1篇
36ANN TRANSL MED------------论文:1篇
37TUMOR BIOL------------论文:1篇
38ISCIENCE------------论文:1篇
39CANCER LETT------------论文:1篇
40CELL SIGNAL------------论文:1篇
41ONCOGENE------------论文:1篇
42AM J PHYSIOL-CELL PH------------论文:1篇
43PROSTATE------------论文:1篇
44J PINEAL RES------------论文:1篇
没有数据!
序号 名称   论文数量
您需要订阅学者后可以查看Email信息!
您需要订阅学者后可以查看发文曾用名!
您需要订阅学者后可以查看机构轨迹!
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3